MMP9 and inflammatory bowel disease: This is relevant for prospective studies on PPARγ ligands and AnxA1, as knowing that inhibition of MMP-9 secretion is dependent on PPARγ makes it more likely that other PPARγ ligands studied for treatment of IBD would have the same effect in preventing AnxA1 cleaving.